The head of the " />
The head of the "/>
The head of the ">

FDA willing to fast track COVID-19 vaccine before phase three trials end

Arirang News 2020-08-31

Views 11

미국 FDA "코로나19 백신 3상 임상시험 전에 승인할수도"

The head of the U.S. Food and Drug Administration is willing to bypass the full federal approval process in order to make a COVID-19 vaccine available as soon as possible.
In an interview with The Financial Times,... Stephen Hahn said an emergency authorization could be appropriate before phase three clinical trials are completed,... if the benefits outweigh the risks.
He added it's up to the vaccine developer to apply for approval,... and for the FDA to decide on giving it the green light.
Brazil, which has the second most COVID-19 cases,... is also looking into fast tracking its approval process for a potential vaccine,... which normally takes up to 60 days.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
play
00:51

U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
FDA concludes
play
01:51

FDA concludes "no specific concerns" identified in Moderna's COVID-19 vaccine
U.S. FDA to delay emergency authorization of AstraZeneca vaccine until next year: Report
play
02:32

U.S. FDA to delay emergency authorization of AstraZeneca vaccine until next year: Report
U.S. FDA confirms Pfizer's vaccine meets standard for emergency use authorization
play
00:46

U.S. FDA confirms Pfizer's vaccine meets standard for emergency use authorization
U.S. FDA approves Moderna's COVID-19 vaccine
play
00:39

U.S. FDA approves Moderna's COVID-19 vaccine
U.S. FDA authorizes Pfizer's COVID-19 vaccine for emergency use
play
00:33

U.S. FDA authorizes Pfizer's COVID-19 vaccine for emergency use
Moderna and Pfizer vaccine candidates moving closer to FDA authorization
play
02:36

Moderna and Pfizer vaccine candidates moving closer to FDA authorization
U.S. FDA revises guidelines for Pfizer/BioNTech COVID-19 vaccines following reports of side effects
play
00:35

U.S. FDA revises guidelines for Pfizer/BioNTech COVID-19 vaccines following reports of side effects
FDA concludes
play
01:46

FDA concludes "no specific concerns" identified to Moderna's COVID-19 vaccine
Outside experts of U.S. FDA endorse Moderna's COVID-19 vaccine
play
01:58

Outside experts of U.S. FDA endorse Moderna's COVID-19 vaccine
U.S. FDA advisors recommend Pfizer vaccine for emergency use
play
01:53

U.S. FDA advisors recommend Pfizer vaccine for emergency use
U.S. FDA approves Moderna vaccine for emergency use
play
00:37

U.S. FDA approves Moderna vaccine for emergency use